Transcripts Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
23:00:00 17/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.880 USD | +6.67% |
|
-3.68% | +4.73% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
Transcripts
Search
No results match your criteria
Select your edition
All financial news and data tailored to specific country editions
















